Company / PP&E per Share
Adaptimmune Therapeutics PLC PP&E per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.02
FY2024
5-year range
$0.02 / $0.06
FY2020-FY2024
Trend
-55.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share has fluctuated over the past 9 years, ranging from $0.02 in FY2024 to $0.10 in FY2017.
Based on SEC 10-K filings.
0.02 in FY2024 with a 5-year CAGR of -14.2%.
Declined from $0.06 to $0.02 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -11.2%
- 5-Year CAGR
- -14.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, pp&e per share decreased 55.5% year-over-year.
- Peak pp&e per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.02 | -55.5% |
| FY2023 | $0.05 | -10.5% |
| FY2022 | $0.06 | +75.5% |
| FY2021 | $0.03 | -25.4% |
| FY2020 | $0.04 | -11.1% |
| FY2019 | $0.05 | -22.9% |
| FY2018 | $0.06 | -32.9% |
| FY2017 | $0.10 | +45.8% |
| FY2016 | $0.07 | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026